市場調査レポート

商品コード

肺がん検診の2030年までの市場規模と予測-がん種、技術、年齢層、エンドユーザー別の世界分析

Lung Cancer Screening Market Size and Forecast to 2030 - Global Analysis by Cancer Type, Technology, Age Group (50 & Older and Below 50), and End User (Hospitals, Diagnostic Centers, and Others)

出版日: 2023年07月05日
発行: The Insight Partners
ページ情報: 英文 188 Pages
納期: 即納可能

価格

PDF (Single User License)

USD 4,450 653,349円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 6,450 946,989円

レポートPDFを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 8,450 1,240,629円

レポートPDFを企業内すべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.82円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

肺がん検診市場規模は、2022年の23億2,650万米ドルから2030年には43億6,395万米ドルに成長すると予測され、2022年から2030年までのCAGRは8.2%を記録すると推定されます。

肺がん検診市場の成長は、肺がん罹患率の上昇と政府支援の増加に起因しています。しかし、肺がん検診の検査費用が高いことが肺がん検診市場の成長を妨げています。

肺がん検診は、肺がんリスクの高い健康な人の肺がんを発見するためのプロセスです。肺がん検診は、長年の喫煙者で肺がんの兆候や症状がない高齢者に推奨されます。医師は肺のLDCTスキャンで肺がんを調べます。肺がんが早期に発見されれば、治療によって治癒する可能性が高くなります。

政府支援の高まりが肺がん検診市場の成長を後押し

米国予防サービス専門委員会は、55～80歳の喫煙歴30本年（1日20本のタバコを30年間吸い続けたのと同じ）の人で、現在喫煙しているか、過去15年以内に禁煙している人に、年1回の低線量コンピュータ断層撮影（LDCT）肺がん検診を受けることを推奨しています。

Cancer Australia 2023の報告書によると、肺がんはオーストラリアで最も一般的ながんであり、死亡率の大部分を占めています。さらに、肺がんの早期発見は生存率の向上に役立ちます。また、新しい検診プログラムは、治療が成功しにくい初期の段階で肺がんを発見するのに役立ちます。例えば、2021年7月、キャンサー・オーストラリアは、オーストラリアにおける肺がん検診プログラムの実現可能性を判断するため、保健・高齢者医療省と提携しました。

このような政府支援の高まり、政策、複数の政府による承認が肺がん検診市場の成長を後押ししています。

肺がん検診市場- がんタイプ別洞察

肺がん検診市場は、がんの種類によってNSCLCと小細胞肺がんに二分されます。NSCLCセグメントは2022年に最大の市場シェアを占め、予測期間中にCAGR 10.3%で成長する見込みです。このセグメントの市場地位は、世界中でNSCLCの症例が増加していることによる。NSCLCは小細胞肺がんよりも発病が遅いです。NSCLCは通常、診断されるまでに患者の身体の他の部分に転移します。したがって、早期診断と早期治療が重要です。全米がん研究財団によると、NSCLCは10人中9人近くを占めています。同出典によると、大細胞未分化がん肺がんはNSCLC診断全体の約10～15％を占める。

肺がん検診市場-技術的洞察

技術に基づき、肺がん検診市場はLDCT、胸部X線、リキッドバイオプシー、その他に区分されます。LDCTは2022年に最大の市場シェアを占め、予測期間中にCAGR 8.0%で成長すると予測されます。

肺がん検診市場-年齢層別洞察

年齢層に基づき、肺がん検診市場は50歳以上と50歳未満に二分されます。50歳以上セグメントは2022年に最大の市場シェアを占めたが、50歳未満セグメントは予測期間中にCAGR 8.9%で成長する見込みです。

肺がん検診市場- エンドユーザー別洞察

エンドユーザーに基づき、肺がん検診市場は病院、診断センター、その他に区分されます。ホスピタリティセグメントが2022年に最大の市場シェアを占めたが、その他は予測期間中にCAGR 8.7%で成長すると予測されます。

肺がん検診市場- 最近の市場開拓：

肺がん検診市場では、M&Aなどの無機的・有機的戦略が企業によって高度に採用されています。最近の主な市場開拓をいくつか以下に示す：

2021年11月、GEヘルスケアとOptellum社は肺がんの精密診断と治療を推進するために提携しました。両社は共同で、肺がん診断における最大の課題の1つである肺結節（良性またはがんの可能性がある疑わしい病変）の悪性度を医療従事者が判断できるようにすることに取り組んでいます。

2022年6月、ロイヤル・フィリップスはバイオデシックス社と提携し、バイオデシックス社の血液ベースの肺結節リスク評価検査Nodify Lungの結果をフィリップスの肺がん患者管理システムLung Cancer Orchestratorに組み込んでいます。プロテオミクスデータは、現在治療方針の決定に使用されている放射線学的データおよび患者の病歴データとともに、Lung Cancer Orchestrator内のBiodesix Nodify Lungアプリケーションのコンテキスト起動により、増加する肺結節症例の管理において、がん医療センターの診断効率を高めるのに役立ちます。

2021年5月、Genetron Holdings Limitedは中国医療機器フェアでシーメンス・ヘルスイニアーズと提携しました。この提携は、非小細胞肺がん（NSCLC）患者に効率的で正確な個別化診断と治療ガイダンスを提供するため、中国の病院においてジェネトロンのS5プラットフォームと肺がん8遺伝子IVDアッセイの大規模な応用を促進することを目的としています。

List Of Tables

Table 1. North America Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 2030 (US$ Million)
Table 2. North America Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 3. North America Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 4. North America Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 5. US Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 6. US Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 7. US Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 8. US Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 10. Canada Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 11. Canada Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 12. Canada Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. Mexico Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 14. Mexico Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 15. Mexico Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 16. Mexico Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 17. Europe Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 2030 (US$ Million)
Table 18. Europe Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 19. Europe Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 20. Europe Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 21. Germany Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 22. Germany Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 23. Germany Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 24. Germany Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 25. UK Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 26. UK Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 27. UK Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 28. UK Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 29. France Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 30. France Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 31. France Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 32. France Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 33. Italy Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 34. Italy Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 35. Italy Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 36. Italy Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 37. Spain Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 38. Spain Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 39. Spain Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 40. Spain Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 41. Rest of Europe Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 42. Rest of Europe Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 43. Rest of Europe Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 44. Rest of Europe Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 45. Asia Pacific Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 2030 (US$ Million)
Table 46. Asia Pacific Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 47. Asia Pacific Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 48. Asia Pacific Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 49. China Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 50. China Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 51. China Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 52. China Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 53. Japan Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 54. Japan Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 55. Japan Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 56. Japan Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 57. India Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 58. India Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 59. India Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 60. India Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 61. Australia Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 62. Australia Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 63. Australia Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 64. Australia Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 65. South Korea Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 66. South Korea Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 67. South Korea Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 68. South Korea Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 69. Rest of Asia Pacific Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 70. Rest of Asia Pacific Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 71. Rest of Asia Pacific Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 72. Rest of Asia Pacific Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 73. Middle East & Africa Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 2030 (US$ Million)
Table 74. Middle East & Africa Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 75. Middle East & Africa Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 76. Middle East & Africa Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 77. South Africa Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 2030 (US$ Million)
Table 78. South Africa Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 79. South Africa Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 80. South Africa Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 81. Saudi Arabia Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 2030 (US$ Million)
Table 82. Saudi Arabia Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 83. Saudi Arabia Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 84. Saudi Arabia Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 85. UAE Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 2030 (US$ Million)
Table 86. UAE Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 87. UAE Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 88. UAE Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 89. Rest of Middle East & Africa Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 2030 (US$ Million)
Table 90. Rest of Middle East & Africa Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 91. Rest of Middle East & Africa Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 92. Rest of Middle East & Africa Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 93. South & Central America Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 2030 (US$ Million)
Table 94. South & Central America Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 95. South & Central America Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 96. South & Central America Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 97. Brazil Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 98. Brazil Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 99. Brazil Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 100. Brazil Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 101. Argentina Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 102. Argentina Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 103. Argentina Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 104. Argentina Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 105. Rest of South & Central America Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 106. Rest of South & Central America Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 107. Rest of South & Central America Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 108. Rest of South & Central America Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 109. Recent Growth Strategies in the Lung Cancer Screening Market
Table 110. Glossary of Terms

List Of Figures

Figure 1. Lung Cancer Screening Market Segmentation
Figure 2. Lung Cancer Screening Market, by Region
Figure 3. Global Lung Cancer Screening Market Overview
Figure 4. Non-Small Cell Lung Cancer Segment Held Largest Share of Cancer Type Segment in Lung Cancer Screening Market
Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
Figure 6. Lung Cancer Screening Market, by Geography (US$ Million)
Figure 7. Global Lung Cancer Screening Market - Leading Country Markets (US$ Million)
Figure 8. North America: PEST Analysis
Figure 9. Europe: PEST Analysis
Figure 10. Asia Pacific: PEST Analysis
Figure 11. South & Central America: PEST Analysis
Figure 12. Middle East & Africa: PEST Analysis
Figure 13. Experts' Opinion
Figure 14. Lung Cancer Screening Market Impact Analysis of Driver and Restraints
Figure 15. Global Lung Cancer Screening Market - Revenue Forecast and Analysis - 2020-2030
Figure 16. Global Lung Cancer Screening Market, by Geography - Forecast and Analysis (2022 & 2030)
Figure 17. Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)
Figure 18. Non-Small Cell Lung Cancer (NSCLC): Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Small Cell Lung Cancer: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Lung Cancer Screening Market, by Technology, 2022 & 2030 (%)
Figure 21. Low-Dose Computed Tomography (LDCT): Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
Figure 22. Chest X-ray: Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
Figure 23. Liquid Biopsy: Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
Figure 24. Others: Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
Figure 25. Lung Cancer Screening Market, by Age group, 2022 & 2030 (%)
Figure 26. & Older: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Below 50: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Lung Cancer Screening Market, by End User, 2022 & 2030 (%)
Figure 29. Hospitals: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Diagnostic Centers: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Others: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. North America: Lung Cancer Screening Market, by Key Country - Revenue (2022) (US$ Million)
Figure 33. North America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 34. North America: Lung Cancer Screening Market, by Country, 2022 & 2030 (%)
Figure 35. US: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 36. Canada: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 37. Mexico: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 38. Europe: Lung Cancer Screening Market, by Key Country - Revenue (2022) (US$ Million)
Figure 39. Europe Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 40. Europe: Lung Cancer Screening Market, by Country, 2022 & 2030 (%)
Figure 41. Germany: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 42. UK: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 43. France: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 44. Italy: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 45. Spain: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 46. Rest of Europe: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 47. Asia Pacific: Lung Cancer Screening Market, by Key Country - Revenue (2022) (US$ Million)
Figure 48. Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 49. Asia Pacific: Lung Cancer Screening Market, by Country, 2022 & 2030 (%)
Figure 50. China: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 51. Japan: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 52. India: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 53. Australia: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 54. South Korea: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 55. Rest of Asia Pacific: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 56. Middle East & Africa: Lung Cancer Screening Market, by Key Country - Revenue (2022) (US$ Million)
Figure 57. Middle East & Africa Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 58. Middle East & Africa: Lung Cancer Screening Market, by Country, 2022 & 2030 (%)
Figure 59. South Africa: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 60. Saudi Arabia: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 61. UAE: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 62. Rest of Middle East & Africa: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 63. South & Central America: Lung Cancer Screening Market, by Key Country - Revenue (2022) (US$ Million)
Figure 64. South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 65. South & Central America: Lung Cancer Screening Market, by Country, 2022 & 2030 (%)
Figure 66. Brazil: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 67. Argentina: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 68. Rest of South & Central America: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 69. Pre and Post Impact of COVID-19 Pandemic on Markets

Product Code: TIPRE00029996

The lung cancer screening market size is expected to grow from US$ 2,326.5 million in 2022 to US$ 4,363.95 million by 2030; it is estimated to record a CAGR of 8.2% from 2022 to 2030.

The lung cancer screening market growth is attributed to the rising lung cancer Incidence and increasing government support. However, the high cost of lung screening tests is hampering the growth of the lung cancer screening market.

Lung cancer screening is a process used to detect lung cancer in otherwise healthy people with a high risk of lung cancer. Lung cancer screening is recommended for older adults who are long time smokers and who don't have any signs or symptoms of lung cancer. Doctors use a LDCT scan of the lungs to look for lung cancer. If lung cancer is detected early, it's more likely to be cured with treatment.

Rising Government Supportis Boosting The Growth Of The Lung Cancer Screening Market

The United States Preventive Services Task Force recommends people aged 55-80 with a 30-pack-year (equivalent to smoking 20 cigarettes per day for 30 years) smoking history who are presently smoking or have quit within the last 15 years to undergo annual low-dose computed tomography (LDCT) screening for lung cancer.

As per the Cancer Australia 2023 report, lung cancer is the most common form of cancer in Australia, accounting for the majority of the mortality rates. Furthermore, early detection of lung cancer helps improve survival rates. Also, the new screening program will help detect lung cancer during the early stages when treatment is not likely to be successful. For example, in July 2021, Cancer Australia partnered with the Department of Health and Aged Care to determine the feasibility of a lung cancer screening program in Australia.

Such rising government support, policies, and approvals by several governments are boosting the growth of the lung cancer screening market.

Lung Cancer Screening Market - Cancer Type Insights

Based on cancer type, the lung cancer screening market is bifurcated into NSCLC and small cell lung cancer. The NSCLC segment accounted for the largest market share in 2022 and is expected to grow at a CAGR of 10.3% during the forecast period. The market position of this segment is due to the rising cases of NSCLC over the globe. NSCLC develops more slowly than small cell lung cancer. It usually spreads to other parts of the patient's body by the time it is diagnosed. Therefore, early diagnosis and treatment are crucial. According to National Foundation for Cancer Research, NSCLC accounts for nearly 9 out of every 10 diagnoses. As per the same source, large-cell undifferentiated carcinoma lung cancer accounts for approximately 10-15% of all NSCLC diagnoses.

Lung Cancer Screening Market - Technology Insights

Based on technology, the Lung cancer screening market is segmented into LDCT, chest X-ray, liquid biopsy, and others. The LDCT accounted for the largest market share in 2022 and same is expected to grow at a CAGR of 8.0% during the forecast period.

Lung Cancer Screening Market - Age Group Insights

Based on age group, the lung cancer screening market is bifurcated into 50 & older and below 50. The 50 & older segment accounted for the largest market share in 2022, however, the below 50 is expected to grow at a CAGR of 8.9% during the forecast period.

Lung Cancer Screening Market - End User Insights

Based on end user, the lung cancer screening market is segmented into hospitals, diagnostic centers, and others. The hospitals segment accounted for the largest market share in 2022, however, the others is expected to grow at a CAGR of 8.7% during the forecast period.

Lung Cancer Screening Market - Recent Developments:

Inorganic and organic strategies such as mergers and acquisitions are highly adopted by companies in the lung cancer screening market. A few recent key market developments are listed below:

In November 2021, GE Healthcare and Optellum collaborated to advance precision diagnosis and treatment of lung cancer. Together, the companies are seeking to address one of the largest challenges in diagnosing lung cancer, helping providers to determine the malignancy of a lung nodule: a suspicious lesion that may be benign or cancerous.

In June 2022, Royal Philips teamed up with Biodesix, Inc. to incorporate the results of Biodesix's Nodify Lung blood-based lung nodule risk assessment testing into Philips Lung Cancer Orchestrator lung cancer patient management system. The incorporation of proteomics data - along with the radiologic and patient history data currently used to determine treatment decisions can help create diagnostic efficiency for cancer care centers in the management of a growing number of lung nodule cases via the contextual launch of Biodesix Nodify Lung application within Lung Cancer Orchestrator.

In May 2021, Genetron Holdings Limited has partnered with Siemens Healthineers at the China Medical Equipment Fair. This partnership aims to promote the large-scale application of Genetron's S5 platform and lung cancer 8-gene IVD assay in Chinese hospitals to provide non-small cell lung cancer (NSCLC) patients with efficient and accurate personalized diagnosis and treatment guidance.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the lung cancer screening market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the lung cancer screening market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction

1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Global Lung Cancer Screening Market - by Technology
- 1.3.2 Global Lung Cancer Screening Market - by Cancer Type
- 1.3.3 Global Lung Cancer Screening Market - by Age Group
- 1.3.4 Global Lung Cancer Screening Market - by End User
- 1.3.5 Global Lung Cancer Screening Market - by Geography

2. Lung Cancer Screening Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Lung Cancer Screening Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
- 4.2.2 Europe PEST Analysis
- 4.2.3 Asia Pacific PEST Analysis
- 4.2.4 South & Central America PEST Analysis
- 4.2.5 Middle East & Africa PEST Analysis
4.3 Expert's Opinion

5. Lung Cancer Screening Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Lung Cancer Incidences
- 5.1.2 Increasing Government Support
5.2 Market Restraints
- 5.2.1 High Cost of Lung Cancer Screening Tests
5.3 Market Opportunities
- 5.3.1 Structured Lung Cancer Screening Program
5.4 Future Trends
- 5.4.1 Mobile Lung Cancer Screening Truck
5.5 Impact Analysis

6. Lung Cancer Screening Market - Global Analysis

6.1 Global Lung Cancer Screening Market Revenue Forecast and Analysis
6.2 Global Lung Cancer Screening Market, by Geography - Forecast and Analysis

7. Global Lung Cancer Screening Market - Revenue and Forecast to 2028 - By Cancer Type

7.1 Overview
7.2 Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)
7.3 Non-Small Cell Lung Cancer (NSCLC)
- 7.3.1 Overview
- 7.3.2 Non-Small Cell Lung Cancer (NSCLC): Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Mn)
7.4 Small Cell Lung Cancer
- 7.4.1 Overview
- 7.4.2 Small Cell Lung Cancer: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)

8. Lung Cancer Screening Market Analysis - by Technology

8.1 Overview
8.2 Low-Dose Computed Tomography (LDCT)
- 8.2.1 Overview
- 8.2.2 Low-Dose Computed Tomography (LDCT): Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
8.3 Chest X-ray
- 8.3.1 Overview
- 8.3.2 Chest X-ray: Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
8.4 Liquid Biopsy
- 8.4.1 Overview
- 8.4.2 Liquid Biopsy: Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)

9. Lung Cancer Screening Market Analysis - by Age Group

9.1 Overview
9.2 & Older
- 9.2.1 Overview
- 9.2.2 & Older: Australia Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Below 50
- 9.3.1 Overview
- 9.3.2 Below 50: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)

10. Lung Cancer Screening Market Analysis - by End User

10.1 Overview
10.2 Hospitals
- 10.2.1 Overview
- 10.2.2 Hospitals: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
10.3 Diagnostic Centers
- 10.3.1 Overview
- 10.3.2 Diagnostic Centers: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Others
- 10.4.1 Overview
- 10.4.2 Others: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)

11. Lung Cancer Screening Market - Revenue and Forecast to 2028 - Geographic Analysis

11.1 North America: Lung Cancer Screening Market
- 11.1.1 Overview
- 11.1.2 North America: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.3 North America: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
- 11.1.4 North America: Lung Cancer Screening Market, by Technology - 2020-2030 (US$ Million)
- 11.1.5 North America: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
- 11.1.6 North America: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.1.6.1 US: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.6.1.1 Overview
    - 11.1.6.1.2 US: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.6.1.3 US: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.1.6.1.4 US: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.6.1.5 US: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.1.6.1.6 US: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.1.6.2 Canada: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.6.2.1 Overview
    - 11.1.6.2.2 Canada: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.6.2.3 Canada: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.1.6.2.4 Canada: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.6.2.5 Canada: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.1.6.2.6 Canada: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.1.6.3 Mexico: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.6.3.1 Overview
    - 11.1.6.3.2 Mexico: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.6.3.3 Mexico: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.1.6.3.4 Mexico: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.6.3.5 Mexico: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.1.6.3.6 Mexico: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.2 Europe: Lung Cancer Screening Market
- 11.2.1 Overview
- 11.2.2 Europe: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
- 11.2.3 Europe: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
- 11.2.4 Europe: Lung Cancer Screening Market, by Technology - 2020-2030 (US$ Million)
- 11.2.5 Europe: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
- 11.2.6 Europe: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.2.6.1 Germany: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.1.1 Overview
    - 11.2.6.1.2 Germany: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.1.3 Germany: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.2.6.1.4 Germany: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.1.5 Germany: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.2.6.1.6 Germany: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.2.6.2 UK: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.2.1 Overview
    - 11.2.6.2.2 UK: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.2.3 UK: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.2.6.2.4 UK: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.2.5 UK: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.2.6.2.6 UK: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.2.6.3 France: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.3.1 Overview
    - 11.2.6.3.2 France: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.3.3 France: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.2.6.3.4 France: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.3.5 France: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.2.6.3.6 France: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.2.6.4 Italy: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.4.1 Overview
    - 11.2.6.4.2 Italy: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.4.3 Italy: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.2.6.4.4 Italy: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.4.5 Italy: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.2.6.4.6 Italy: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.2.6.5 Spain: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.5.1 Overview
    - 11.2.6.5.2 Spain: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.5.3 Spain: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.2.6.5.4 Spain: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.5.5 Spain: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.2.6.5.6 Spain: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.2.6.6 Rest of Europe: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.6.1 Overview
    - 11.2.6.6.2 Rest of Europe: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.6.3 Rest of Europe: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.2.6.6.4 Rest of Europe: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.6.6.5 Rest of Europe: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.2.6.6.6 Rest of Europe: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.3 Asia-Pacific: Lung Cancer Screening Market
- 11.3.1 Overview
- 11.3.2 Asia Pacific: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
- 11.3.3 Asia Pacific: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
- 11.3.4 Asia Pacific: Lung Cancer Screening Market, by Technology - 2020-2030 (US$ Million)
- 11.3.5 Asia Pacific: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
- 11.3.6 Asia Pacific: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.3.6.1 China: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.1.1 Overview
    - 11.3.6.1.2 China: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.1.3 China: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.3.6.1.4 China: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.1.5 China: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.3.6.1.6 China: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.3.6.2 Japan: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.2.1 Overview
    - 11.3.6.2.2 Japan: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.2.3 Japan: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.3.6.2.4 Japan: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.2.5 Japan: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.3.6.2.6 Japan: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.3.6.3 India: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.3.1 Overview
    - 11.3.6.3.2 India: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.3.3 India: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.3.6.3.4 India: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.3.5 India: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.3.6.3.6 India: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.3.6.4 Australia: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.4.1 Overview
    - 11.3.6.4.2 Australia: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.4.3 Australia: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.3.6.4.4 Australia: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.4.5 Australia: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.3.6.4.6 Australia: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.3.6.5 South Korea: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.5.1 Overview
    - 11.3.6.5.2 South Korea: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.5.3 South Korea: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.3.6.5.4 South Korea: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.5.5 South Korea: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.3.6.5.6 South Korea: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.3.6.6 Rest of Asia Pacific: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.6.1 Overview
    - 11.3.6.6.2 Rest of Asia Pacific: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.6.3 Rest of Asia Pacific: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.3.6.6.4 Rest of Asia Pacific: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.3.6.6.5 Rest of Asia Pacific: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.3.6.6.6 Rest of Asia Pacific: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.4 Middle East & Africa: Lung Cancer Screening Market
- 11.4.1 Overview
- 11.4.2 Middle East & Africa: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
- 11.4.3 Middle East & Africa: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
- 11.4.4 Middle East & Africa: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)
- 11.4.5 Middle East & Africa Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
  - 11.4.5.2 South Africa: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.4.5.2.1 Overview
    - 11.4.5.2.2 South Africa: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.4.5.2.3 South Africa: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.4.5.2.4 South Africa: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)
    - 11.4.5.2.5 South Africa Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.4.5.2.6 South Africa: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.4.5.3 Saudi Arabia: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.4.5.3.1 Overview
    - 11.4.5.3.2 Saudi Arabia: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.4.5.3.3 Saudi Arabia: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.4.5.3.4 Saudi Arabia: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)
    - 11.4.5.3.5 Saudi Arabia Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.4.5.3.6 Saudi Arabia: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.4.5.4 UAE: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.4.5.4.1 Overview
    - 11.4.5.4.2 UAE: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.4.5.4.3 UAE: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.4.5.4.4 UAE: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)
    - 11.4.5.4.5 UAE Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.4.5.4.6 UAE: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.4.5.5 Rest of Middle East & Africa: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.4.5.5.1 Overview
    - 11.4.5.5.2 Rest of Middle East & Africa: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.4.5.5.3 Rest of Middle East & Africa: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.4.5.5.4 Rest of Middle East & Africa: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)
    - 11.4.5.5.5 Rest of Middle East & Africa Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.4.5.5.6 Rest of Middle East & Africa: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.5 South & Central America: Lung Cancer Screening Market
- 11.5.1 Overview
- 11.5.2 South & Central America: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
- 11.5.3 South & Central America: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
- 11.5.4 South & Central America: Lung Cancer Screening Market, by Technology - 2020-2030 (US$ Million)
- 11.5.5 South & Central America: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
- 11.5.6 South & Central America: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.5.6.1 Brazil: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.5.6.1.1 Overview
    - 11.5.6.1.2 Brazil: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.5.6.1.3 Brazil: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.5.6.1.4 Brazil: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.5.6.1.5 Brazil: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.5.6.1.6 Brazil: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.5.6.2 Argentina: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.5.6.2.1 Overview
    - 11.5.6.2.2 Argentina: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.5.6.2.3 Argentina: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.5.6.2.4 Argentina: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.5.6.2.5 Argentina: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.5.6.2.6 Argentina: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  - 11.5.6.3 Rest of South & Central America: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.5.6.3.1 Overview
    - 11.5.6.3.2 Rest of South & Central America: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.5.6.3.3 Rest of South & Central America: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    - 11.5.6.3.4 Rest of South & Central America: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
    - 11.5.6.3.5 Rest of South & Central America: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    - 11.5.6.3.6 Rest of South & Central America: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)

12. Pre and Post COVID-19 Impact on Lung Cancer Screening Market

12.1 Impact Analysis of COVID-19 Pandemic on Lung Cancer Screening Market

13. Lung Cancer Screening Market-Industry Landscape

13.1 Recent Growth Strategies
- 13.1.1 Overview

14. Company Profiles

14.1 Intelerad Medical Systems
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Nuance Communications Inc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 GE HealthCare
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Medtronic
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Canon Inc.
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Koninklijke Philips NV
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Siemens AG
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 CVS Health
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 bioAffinity Technologies, Inc.
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 LungLife AI, Inc.
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms

肺がん検診の2030年までの市場規模と予測-がん種、技術、年齢層、エンドユーザー別の世界分析

Lung Cancer Screening Market Size and Forecast to 2030 - Global Analysis by Cancer Type, Technology, Age Group (50 & Older and Below 50), and End User (Hospitals, Diagnostic Centers, and Others)

目次

第1章イントロダクション

第2章肺がん検診市場-要点

第3章調査手法

第4章肺がん検診市場-市場情勢

第5章肺がん検診市場-主要市場力学

第6章肺がん検診市場-世界分析

第7章肺がん検診の世界市場：収益と2028年までの予測：がんタイプ別

第8章肺がん検診市場分析-技術別

第9章肺がん検診市場分析：年齢層別

第10章肺がん検診市場分析-エンドユーザー別

第11章肺がん検診市場～2028年までの収益と予測- 地域別市場分析

第12章 COVID-19前後の肺がん検診市場への影響

第13章肺がん検診市場-業界情勢

第14章企業プロファイル

第15章企業プロファイル付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Lung Cancer Screening Market - Key Takeaways

3. Research Methodology

4. Lung Cancer Screening Market - Market Landscape

5. Lung Cancer Screening Market - Key Market Dynamics

6. Lung Cancer Screening Market - Global Analysis

7. Global Lung Cancer Screening Market - Revenue and Forecast to 2028 - By Cancer Type

8. Lung Cancer Screening Market Analysis - by Technology

9. Lung Cancer Screening Market Analysis - by Age Group

10. Lung Cancer Screening Market Analysis - by End User

11. Lung Cancer Screening Market - Revenue and Forecast to 2028 - Geographic Analysis

12. Pre and Post COVID-19 Impact on Lung Cancer Screening Market

13. Lung Cancer Screening Market-Industry Landscape

14. Company Profiles

15. Appendix

肺がん検診の2030年までの市場規模と予測-がん種、技術、年齢層、エンドユーザー別の世界分析

Lung Cancer Screening Market Size and Forecast to 2030 - Global Analysis by Cancer Type, Technology, Age Group (50 & Older and Below 50), and End User (Hospitals, Diagnostic Centers, and Others)

目次

第1章 イントロダクション

第2章 肺がん検診市場-要点

第3章 調査手法

第4章 肺がん検診市場-市場情勢

第5章 肺がん検診市場-主要市場力学

第6章 肺がん検診市場-世界分析

第7章 肺がん検診の世界市場：収益と2028年までの予測：がんタイプ別

第8章 肺がん検診市場分析-技術別

第9章 肺がん検診市場分析：年齢層別

第10章 肺がん検診市場分析-エンドユーザー別

第11章 肺がん検診市場～2028年までの収益と予測- 地域別市場分析

第12章 COVID-19前後の肺がん検診市場への影響

第13章 肺がん検診市場-業界情勢

第14章 企業プロファイル

第15章 企業プロファイル付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Lung Cancer Screening Market - Key Takeaways

3. Research Methodology

4. Lung Cancer Screening Market - Market Landscape

5. Lung Cancer Screening Market - Key Market Dynamics

6. Lung Cancer Screening Market - Global Analysis

7. Global Lung Cancer Screening Market - Revenue and Forecast to 2028 - By Cancer Type

8. Lung Cancer Screening Market Analysis - by Technology

9. Lung Cancer Screening Market Analysis - by Age Group

10. Lung Cancer Screening Market Analysis - by End User

11. Lung Cancer Screening Market - Revenue and Forecast to 2028 - Geographic Analysis

12. Pre and Post COVID-19 Impact on Lung Cancer Screening Market

13. Lung Cancer Screening Market-Industry Landscape

14. Company Profiles

15. Appendix

第1章イントロダクション

第2章肺がん検診市場-要点

第3章調査手法

第4章肺がん検診市場-市場情勢

第5章肺がん検診市場-主要市場力学

第6章肺がん検診市場-世界分析

第7章肺がん検診の世界市場：収益と2028年までの予測：がんタイプ別

第8章肺がん検診市場分析-技術別

第9章肺がん検診市場分析：年齢層別

第10章肺がん検診市場分析-エンドユーザー別

第11章肺がん検診市場～2028年までの収益と予測- 地域別市場分析

第13章肺がん検診市場-業界情勢

第14章企業プロファイル

第15章企業プロファイル付録